ATRIA 6100TM COMBINES CLINICAL PERFORMANCE WITH LEADING EDGE TECHNOLOGY
Cardiac Science Corporation,
announced today that the U.S. Food and Drug Administration (FDA) has granted the Company510(k) regulatory
clearance to market a new resting electrocardiograph, the
Atria 6100.
más>> |